HTA Database - Search Results

Sort by Relevance

Search Results [15922 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2010	National Institute for Health and Care Excellence (NICE)	Therapeutic endoscopic division of epidural adhesions. NICE interventional procedures guidance 333
2010	Canary Health Service	[Barriers and facilitators to implementation of shared decision-making]
2010	Canary Health Service	[Cost-effectiveness of knowledge transfer methods]
2010	Canary Health Service	[Effectiveness of cardiovascular risk communication]
2010	Canary Health Service	[Shared decision making in the choice of statins for patients with type two diabetes]
2010	Canary Health Service	[Cost-effectiveness of isolated stenting versus stenting with balloon angioplasty and vascular protection in carotid atherosclerosis]
2010	Canary Health Service	[Cost-effectiveness of endovascular treatment versus open surgery in patients with steno-occlusive femoral artery disease]
2010	Canary Health Service	[Development and evaluation of a decision support tool for benign prostatic hyperplasia patients]
2010	Canary Health Service	[Effectiveness of interspinous decompression devices for the treatment of symptomatic lumbar spinal canal stenosis]
2010	Canary Health Service	[Efficacy and effectiveness of competitive employment strategies as a therapeutic intervention for people with disabilities due to severe and persistent mental disorders]
2010	Canary Health Service	[Efficacy, effectiveness and efficiency of assertive community treatment for people with severe and persistent mental disorder and its relationship with the context of application]
2010	Canary Health Service	[Evaluation of an intervention on smoking in secondary education. ITES Program]
2010	Canary Health Service	[Antidepressant drugs and psychological treatments for depressive disorders: an economic review and evaluation]
2010	Canary Health Service	[Decision-making aid tools for patients with depression]
2010	Canary Health Service	[Impact of economic evaluation of health technologies on health decisions: a survey of decision-makers]
2010	Canary Health Service	[Group psychotherapies as a therapeutic technique in people with schizophrenia]
2010	Canary Health Service	[Systematic review of the effectiveness and cost-effectiveness of psychoeducational interventions in people with bipolar disorder and their families]
2010	Canary Health Service	[Cost-effectiveness analysis of prostate cancer screening with prostate-specific antigen associated or not with digital rectal examination in men aged 50 years and older]
2010	National Institute for Health and Care Excellence (NICE)	Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events. NICE technology appraisal guidance 210
2010	National Institute for Health and Care Excellence (NICE)	Prucalopride for the treatment of chronic constipation in women. NICE technology appraisal guidance 211
2010	National Institute for Health and Care Excellence (NICE)	Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer. NICE technology appraisal guidance 212
2010	National Institute for Health and Care Excellence (NICE)	Trastuzumab for the treatment of HER2-positive metastatic gastric cancer. NICE technology appraisal guidance 208
2010	National Institute for Health and Care Excellence (NICE)	Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours. NICE technology appraisal guidance 209
2010	National Institute for Health and Care Excellence (NICE)	Denosumab for the prevention of osteoporotic fractures in postmenopausal women. NICE technology appraisal guidance 204
2010	National Institute for Health and Care Excellence (NICE)	Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal). NICE technology appraisal guidance 206
2010	National Institute for Health and Care Excellence (NICE)	Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal). NICE technology appraisal guidance 207
2010	National Institute for Health and Care Excellence (NICE)	Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C. NICE technology appraisal guidance 200
2010	National Institute for Health and Care Excellence (NICE)	Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor. NICE technology appraisal guidance 195
2010	National Institute for Health and Care Excellence (NICE)	Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis. NICE technology appraisal guidance 199
2010	National Institute for Health and Care Excellence (NICE)	Capecitabine for the treatment of advanced gastric cancer. NICE technology appraisal guidance 191
2010	National Institute for Health and Care Excellence (NICE)	Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer. NICE technology appraisal guidance 192
2010	National Institute for Health and Care Excellence (NICE)	Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia. NICE technology appraisal guidance 193
2010	National Institute for Health and Care Excellence (NICE)	Human growth hormone (somatropin) for the treatment of growth failure in children. NICE technology appraisal guidance 188
2010	National Institute for Health and Care Excellence (NICE)	Infliximab and adalimumab for the treatment of Crohn's disease. NICE technology appraisal guidance 187
2009	NIHR Health Technology Assessment programme	Prostate trials office (PROTO): co-ordinating trials of new technologies in the treatment of BPH
2009	NIHR Health Technology Assessment programme	Development and randomised controlled trial of dipsticks and diagnostic algorithms for the management of UTI
2009	NIHR Health Technology Assessment programme	ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
2009	NIHR Health Technology Assessment programme	A randomised controlled trial to estimate the clinical and cost-effectiveness of four different methods of mechanical support in severe ankle sprains
2009	NIHR Health Technology Assessment programme	Rehabilitation of older patients: day hospital compared to rehabilitation at home. A randomised controlled trial
2009	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Smoking cessation among patients in general practice - a health technology assessment]
2009	The Swedish Council on Health Technology Assessment (SBU)	[Vaccines to children - protective effect and adverse events]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[HIV infection detection quick test]
2009	NIHR Health Technology Assessment programme	Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)
2009	NIHR Health Technology Assessment programme	Paracetamol and Ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial
2009	NIHR Health Technology Assessment programme	Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness
2009	NIHR Health Technology Assessment programme	A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: The VULCAN trial
2009	NIHR Health Technology Assessment programme	A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to11-year-old children with persistent bilateral otitis media with effusion in primary care
2009	NIHR Health Technology Assessment programme	A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell's palsy: the BELLS study
2009	NIHR Health Technology Assessment programme	Controlling hypertension and hypotension immediately post-stroke (CHHIPS) trial
2009	NIHR Health Technology Assessment programme	A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO Trial
2009	NIHR Health Technology Assessment programme	Randomised controlled trial of the use of the three dressing preparations in the management of chronic ulceration of the foot in diabetes
2009	NIHR Health Technology Assessment programme	Randomised controlled trial to determine the clinical and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care. The THREAD (THREshold for AntiDepressant response) study
2009	NIHR Health Technology Assessment programme	VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of psychotherapy for adults with depression]
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	Rehabilitation of breast cancer patients
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of two different strategies to implement the NVOG guideline programme on subfertility]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Costs and effects of two modes for disease management of chronic obstructive pulmonary disease (COPD) in general practice. A randomized controlled trial comparing regular nurse practitioner review and self-management education]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Development of organizational interventions to improve compliance with guidelines on depression and anxiety in primary care]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[FDG-PET for avoidance of futile direct laryngoscopies under general anaesthesia with taking of biopsies in patients with suspicion on recurrent laryngeal carcinoma after radiotherapy]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Foetal growth retardation at term: induction of labour or not? A comparison of maternal and neonatal outcome, maternal quality of life and costs (DIGITAT). The Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT)]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Improving the efficiency and quality of follow-up after curative treatment for breast cancer]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[More efficient use of corneal donor donations: the Dutch Lamellar Corneal Transplantation Study (DLCTS-Study)]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Self-management of asthma supported by hospitals, ICT, nurses and general practitioners]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[The implementation of a guideline on the management of the lumbosacral radicular syndrome among general practitioners, physiotherapists, radiologists, neurologists, neurologic surgeons and orthopedic surgeons: a shared care project in two hospitals]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[When outcome is a balance. Methods to measure combined utility in obstetrics. Ancillary study of Foetal growth retardation at term: induction of labour or not? A comparison of maternal and neonatal outcome, maternal quality of life and costs (DIGITAT). The Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT)]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Endovascular treatment for thoracic aorta lesions]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Accuracy and cost-effectiveness of diagnostic testing in patients with abdominal pain in general practice: a decision analysis]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Exercise therapy in patients with peripheral arterial disease: the costs and effectiveness of physiotherapeutic supervision with or without therapy feedback versus a 'go home and walk' advice]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[FOAM-study. Cost minimization study comparing surgery versus duplex guided foam sclerotherapy of varicose veins: a randomized controlled study]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Improving the early diagnosis of myocardial infarction in primary care: the added value of a rapid assay to detect heart-type FABP, a novel marker of cardiac injury]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Incidence of errors in intensive care: effects of increased awareness and of improved communication by the introduction of explicit daily goals]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Micrometastases and isolated tumour cells: relevant and robust or rubbish? The MIRROR study in breast cancer]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Motivational interviewing embedded in planned diabetes care for Type 2 patients: effectiveness and efficiency in general practice especially to improve guideline recommendations on diet and exercise]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Optimal blood transfusion management in elective orthopaedic surgery]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Outcomes beyond health]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Patient-centred implementation of elective single embryo transfer (eSET) in in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI)]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Percutaneous vertebroplasty in the treatment of osteoporotic vertebral fractures]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Perioperative strategy in colonic surgery; laparoscopy and/or fast track multimodal management versus standard care]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Pregnancy-induced hypertension and pre-eclampsia after 36 weeks: induction of labour versus expectant monitoring. A comparison of maternal and neonatal outcome, maternal quality of life and costs?]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Primary maximal necrosectomy versus a minimally invasive step up approach in patients with necrotising pancreatitis; PANTER, a randomised controlled trial. Dutch Acute Pancreatitis Study Group]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Randomized trial of timing of delivery in early preterm fetal growth restriction based on early and late fetal Doppler venous changes versus cardiotocography. Acronym TRUFFLE = Trial of Umbilical and Fetal Flow in Europe]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[The cost-effectiveness of NT-pro-brain natriuretic peptide (NT-proBNP) guided therapy of chronic heart failure]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[The cost-effectiveness of ST analysis of the fetal electrocardiogram as compared to fetal blood sampling for intrapartum fetal monitoring: a randomised controlled trial]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[The relationship between the cost-effectiveness of blood safety measures and the distribution of patients receiving blood]
2009	Medical Services Advisory Committee (MSAC)	Genotypic resistance testing of antiretrovirals in HIV
2009	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Initial staging of oesophageal cancer: systematic review of the performance of diagnostic methods]
2009	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Permanent and semi permanent dermal fillers
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Technologies to reduce errors in dispensing and administration of medication in hospitals: clinical and economic analyses
2009	NIHR Health Technology Assessment programme	Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care
2009	NIHR Health Technology Assessment programme	How far does screening women for partner violence in different health care settings meet the UK National Screening Committee criteria for a screening programme in terms of condition, screening method and intervention?
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[Misoprostol for induction of labour]
2009	Agency for Healthcare Research and Quality (AHRQ)	Diagnosis and treatment of erectile dysfunction
2009	Andalusian Health Technology Assessment Area (AETSA)	[Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Endovascular treatment of cerebrovascular disease]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Endovascular treatment of cerebrovascular disease]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy and safety of new oral antidiabetics. A systematic review of the literature and economic assessment]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Clinical effectiveness of ozone therapies]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Organisational models in caring type 2 diabetes mellitus patients. Literature review and economic assessment]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Organisational models in caring for patients with cancer]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Organisational models in palliative care. A comparison on consumption of resources]